Total Payments
$15,103
2024 Payments
$47.60
Companies
35
Transactions
198
Medicare Patients
4,038
Medicare Billing
$548,519
Payment Breakdown by Category
Other$10,800 (71.5%)
Food & Beverage$4,053 (26.8%)
Travel$174.49 (1.2%)
Education$75.30 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,800 | 12 | 71.5% |
| Food and Beverage | $4,053 | 178 | 26.8% |
| Travel and Lodging | $174.49 | 2 | 1.2% |
| Education | $75.30 | 2 | 0.5% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$15,103
194 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $11,445 | 32 | $0 (2020) |
| ABBVIE INC. | $920.21 | 53 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $380.06 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $290.06 | 17 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $227.92 | 13 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $194.16 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $173.08 | 4 | $0 (2018) |
| Covidien LP | $170.48 | 1 | $0 (2018) |
| Echosens North America, Inc. | $139.54 | 1 | $0 (2023) |
| Takeda Pharmaceuticals America, Inc. | $115.19 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.60 | 4 | ABBVIE INC. ($18.14) |
| 2023 | $1,030 | 45 | AbbVie Inc. ($245.10) |
| 2022 | $300.26 | 17 | ABBVIE INC. ($120.90) |
| 2021 | $306.05 | 10 | AbbVie Inc. ($136.79) |
| 2020 | $1,341 | 10 | Allergan, Inc. ($1,217) |
| 2019 | $2,317 | 47 | Allergan Inc. ($1,693) |
| 2018 | $5,679 | 34 | Allergan Inc. ($5,012) |
| 2017 | $4,083 | 31 | Allergan Inc. ($3,523) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Gastroenterology | ||||||
| 02/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/19/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Immunology | ||||||
| 12/14/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: CNS | ||||||
| 11/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: Immunology | ||||||
| 11/16/2023 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Gastroenterology | ||||||
| 10/17/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $194.16 | General |
| Category: Immunology | ||||||
| 09/20/2023 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $139.54 | General |
| Category: Elastography | ||||||
| 09/07/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GI COLON PREP | ||||||
| 08/30/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology | ||||||
| 08/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Neuroscience | ||||||
| 07/28/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Immunology | ||||||
| 07/19/2023 | AbbVie Inc. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Gastroenterology | ||||||
| 06/20/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 913 | 945 | $924,987 | $127,683 |
| 2022 | 13 | 1,161 | 1,223 | $1.1M | $158,494 |
| 2021 | 13 | 1,083 | 1,170 | $988,903 | $148,159 |
| 2020 | 13 | 881 | 968 | $698,868 | $114,182 |
Total Patients
4,038
Total Services
4,306
Medicare Billing
$548,519
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 131 | 131 | $186,675 | $28,681 | 15.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 181 | 181 | $225,345 | $24,439 | 10.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 86 | 86 | $123,324 | $16,838 | 13.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 84 | 84 | $119,803 | $16,426 | 13.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 173 | 175 | $161,875 | $14,955 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 60 | $12,720 | $6,118 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 64 | $9,600 | $4,270 | 44.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $33,320 | $4,104 | 12.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $9,300 | $3,390 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,200 | $2,878 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 30 | $6,000 | $1,983 | 33.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $18,000 | $1,543 | 8.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 11 | $7,975 | $1,260 | 15.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 19 | $2,850 | $800.47 | 28.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 158 | 158 | $225,150 | $34,765 | 15.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 177 | 177 | $219,303 | $22,357 | 10.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 107 | 107 | $152,785 | $21,361 | 14.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 97 | 97 | $139,098 | $19,411 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 207 | 209 | $188,100 | $17,870 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 138 | $29,256 | $11,938 | 40.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $57,120 | $7,440 | 13.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 112 | $22,400 | $6,319 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $15,088 | $6,178 | 40.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 61 | 61 | $15,250 | $5,150 | 33.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $30,600 | $2,944 | 9.6% |
About Dr. Thomas Arndt, MD
Dr. Thomas Arndt, MD is a Gastroenterology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487614210.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Arndt, MD has received a total of $15,103 in payments from pharmaceutical and medical device companies, with $47.60 received in 2024. These payments were reported across 198 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,800).
As a Medicare-enrolled provider, Arndt has provided services to 4,038 Medicare beneficiaries, totaling 4,306 services with total Medicare billing of $548,519. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oak Lawn, IL
- Active Since 03/24/2006
- Last Updated 12/29/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487614210
Products in Payments
- LINZESS (Drug) $10,874
- VIBERZI (Drug) $619.35
- STELARA (Biological) $484.22
- XIFAXAN (Drug) $273.23
- SKYRIZI (Biological) $192.22
- Barrx (Device) $170.48
- Mavyret (Drug) $154.55
- ZEPOSIA (Drug) $143.06
- FibroScan (Device) $139.54
- Epclusa (Drug) $121.94
- Entyvio (Biological) $117.50
- GATTEX (Drug) $108.25
- ESOPHYX (Device) $107.85
- RINVOQ (Biological) $93.80
- Cimzia (Drug) $88.34
- XELJANZ (Drug) $66.86
- Linzess (Drug) $65.60
- ENTYVIO (Biological) $65.23
- Creon (Drug) $64.66
- TRULANCE (Drug) $58.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oak Lawn
Dr. Rogelio Silva, M.d, M.D
Gastroenterology — Payments: $446,253
Gastroenterology $446,253
Kamran Ayub, Md, MD
Gastroenterology — Payments: $289,123
Gastroenterology $289,123
Brian Blumenstein, Md, MD
Gastroenterology — Payments: $6,525
Gastroenterology $6,525
Imad Elkhatib, M.d, M.D
Gastroenterology — Payments: $5,371
Gastroenterology $5,371
Samir Patel, Md, MD
Gastroenterology — Payments: $4,166
Gastroenterology $4,166
Dr. Hareth Raddawi, Md, MD
Gastroenterology — Payments: $3,959
Gastroenterology $3,959